(A) Left In vivo whole-cell recordings were made from CA1 pyramidal neurons. The TBS was applied through the patch pipette. Right An example of TBS. EPSP-like waveforms were applied in bursts of 10 …
Spike count in TBS and control conditions.
(A) Correlation with the input resistance prior to TBS. (B) Correlation with membrane potential immediately after breaking in. (C) Correlation with initial AP threshold. (D) Correlation with …
(A) Example traces showing a reduction in input resistance. Each trace is the mean of 10 traces. Rin was calculated on hyperpolarizing steps only and the voltage was taken as the minimum within the …
Input resistance and first spike latency in TBS and control conditions.
(A) Examples of synaptic activity prior to testing excitability before and 20 minutes post-TBS. (B) Membrane potential variance prior to and 20 minutes post-TBS. (C) Scatter plot showing no …
(A) Action potential threshold prior to and 20 minutes post-TBS. (B) Comparison of change in threshold between TBS and control cells. (C) AHP amplitude prior to and 20 minutes post-TBS. (D) …
(A-B) Example cell showing that the decrease in excitability is blocked with 0.5mM BAPTA inside the patch pipette. Scatter plots show the response to each of the maximum current injections during …
Spike count, input resistance and first spike latency in TBS condition with BAPTA.
(A-B) Example cell showing that 1mM MK-801 inside the pipette does not prevent the decrease in excitability. Scatter plot shows the response to each of the maximum current injections during the …
Spike count, input resistance and first spike latency in TBS condition with MK801.
(A) Example traces showing the voltage sag caused by Ih pre and 20 min post-TBS. Each trace is the mean of 10 trials. (B) Sag ratio prior to and 20 minutes post-TBS (n = 16). (C) Sag ratio prior to …
Sag ratio in TBS condition without drugs and with BAPTA and MK801.
(A-B) Inclusion of ZD7288 in the patch pipette blocked Ih, abolishing the voltage sag. Each trace shown is the mean of 10 responses. (C-D) Example cell showing the effect of TBS in the presence of …
Spike count, input resistance and first spike latency in TBS condition with ZD7288.
(A-B) Example cell recorded after the application of DTX-K. Scatter plot shows the response to each of the maximum current injections during the testing protocol (grey circles). The red circles mark …
Spike count, input resistance and first spike latency in TBS condition with DTX-K.
(A) Firing rate map of one cell. Lighter colors indicate higher rate. (B) In-field and out-of-field firing rate by lap for the example cell. (C) Mean firing rates outside the place field across the …
In-field, out-of-field firing rates and correlations across laps for place cells in new condition.
(A) Mean firing rates outside the place field across the session. (B) Distribution of the out-of-field firing rate correlations. (C) Mean in-field firing rates across the session. (D) Distribution …
In-field, out-of-field firing rates and correlations across laps for place cells in familiar condition.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Chemical compound, drug | ZD7288 | Tocris Bioscience | Cat. No. 1000 | |
Chemical compound, drug | Dendrotoxin K | Sigma Aldrich | D4183 | |
Chemical compound, drug | MK-801 | Tocris Bioscience | Cat. No. 0924 |